| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.797 | 0.003 | 0.797 | 5 Hydroxytryptamine 1F antagonist | 0.647 0.003 DB00540 0.578 0.004 DBMET00051 0.405 0.005 DBMET00052 0.294 0.005 DBMET00482 | ||
| 0.746 | 0.005 | 0.827 | Spasmolytic | 0.683 0.007 DB00540 0.827 0.004 DBMET00051 0.768 0.005 DBMET00052 0.675 0.007 DBMET00482 | DBMET00051 | |
| 0.734 | 0.01 | 0.79 | Analgesic | 0.79 0.006 DB00540 0.706 0.013 DBMET00051 0.758 0.008 DBMET00052 0.671 0.016 DBMET00482 | DB00540 | |
| 0.714 | 0.004 | 0.749 | Psychostimulant | 0.749 0.004 DB00540 0.696 0.004 DBMET00051 0.728 0.004 DBMET00052 0.619 0.005 DBMET00482 | DB00540 | |
| 0.712 | 0.004 | 0.712 | 5 Hydroxytryptamine 7 antagonist | 0.598 0.004 DB00540 0.486 0.004 DBMET00051 0.323 0.005 DBMET00052 0.334 0.005 DBMET00482 | ||
| 0.623 | 0.016 | 0.623 | Aldehyde oxidase inhibitor | 0.236 0.088 DB00540 0.526 0.029 DBMET00051 0.156 0.134 DBMET00052 0.22 0.095 DBMET00482 | ||
| 0.605 | 0.007 | 0.605 | Anticonvulsant | 0.536 0.01 DB00540 0.582 0.008 DBMET00051 0.51 0.012 DBMET00052 0.55 0.009 DBMET00482 | ||
| 0.58 | 0.005 | 0.58 | P-glycoprotein inhibitor | 0.517 0.007 DB00540 0.535 0.006 DBMET00051 0.489 0.009 DBMET00052 0.461 0.011 DBMET00482 | ||
| 0.558 | 0.003 | 0.558 | 5 Hydroxytryptamine 5A antagonist | 0.424 0.003 DB00540 0.111 0.013 DBMET00051 0.082 0.023 DBMET00052 0.064 0.038 DBMET00482 | ||
| 0.564 | 0.014 | 0.564 | Histamine release inhibitor | 0.499 0.029 DB00540 0.544 0.017 DBMET00051 0.483 0.035 DBMET00052 0.529 0.02 DBMET00482 | ||
| 0.59 | 0.056 | 0.721 | Antiinflammatory | 0.571 0.062 DB00540 0.686 0.033 DBMET00051 0.671 0.036 DBMET00052 0.721 0.027 DBMET00482 | DBMET00482 | |
| 0.539 | 0.006 | 0.539 | Anesthetic general | 0.445 0.012 DB00540 0.486 0.009 DBMET00051 0.385 0.018 DBMET00052 0.407 0.015 DBMET00482 | ||
| 0.526 | 0.003 | 0.526 | 5 Hydroxytryptamine 5 antagonist | 0.401 0.003 DB00540 0.097 0.016 DBMET00051 0.072 0.025 DBMET00052 0.056 0.044 DBMET00482 | ||
| 0.514 | 0.004 | 0.516 | Alpha 2b adrenoreceptor antagonist | 0.516 0.004 DB00540 0.25 0.014 DBMET00051 0.251 0.014 DBMET00052 0.138 0.045 DBMET00482 | DB00540 | |
| 0.519 | 0.024 | 0.519 | Vasodilator, peripheral | 0.431 0.046 DB00540 0.459 0.038 DBMET00051 0.36 0.069 DBMET00052 0.23 0.144 DBMET00482 | ||
| 0.491 | 0.005 | 0.491 | Nav1.2 sodium channel blocker | 0.472 0.005 DB00540 0.304 0.014 DBMET00051 0.289 0.016 DBMET00052 0.263 0.02 DBMET00482 | ||
| 0.493 | 0.008 | 0.493 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.401 0.021 DB00540 0.371 0.029 DBMET00051 0.295 0.068 DBMET00052 0.36 0.032 DBMET00482 | ||
| 0.477 | 0.004 | 0.477 | Nav1.3 sodium channel blocker | 0.471 0.004 DB00540 0.223 0.018 DBMET00051 0.22 0.019 DBMET00052 0.138 0.056 DBMET00482 | ||
| 0.468 | 0.018 | 0.468 | HERG channel blocker | 0.264 0.061 DB00540 0.21 0.084 DBMET00051 | ||
| 0.458 | 0.014 | 0.458 | Sigma receptor agonist | 0.361 0.028 DB00540 0.237 0.051 DBMET00051 0.15 0.085 DBMET00052 | ||
| 0.442 | 0.005 | 0.442 | Anesthetic local | 0.354 0.009 DB00540 0.367 0.008 DBMET00051 0.286 0.014 DBMET00052 0.193 0.034 DBMET00482 | ||
| 0.437 | 0.004 | 0.437 | Alpha 2a adrenoreceptor antagonist | 0.426 0.004 DB00540 0.195 0.014 DBMET00051 0.19 0.015 DBMET00052 0.112 0.032 DBMET00482 | ||
| 0.436 | 0.004 | 0.436 | Histamine H1 receptor antagonist | 0.31 0.006 DB00540 0.346 0.005 DBMET00051 0.239 0.01 DBMET00052 0.161 0.021 DBMET00482 | ||
| 0.43 | 0.005 | 0.43 | Acetylcholine M1 receptor antagonist | 0.365 0.008 DB00540 0.362 0.008 DBMET00051 0.303 0.014 DBMET00052 0.303 0.014 DBMET00482 | ||
| 0.43 | 0.005 | 0.43 | Antihistaminic | 0.344 0.008 DB00540 0.229 0.016 DBMET00051 0.179 0.025 DBMET00052 0.098 0.057 DBMET00482 | ||
| 0.489 | 0.064 | 0.489 | Caspase 9 stimulant | 0.42 0.099 DB00540 0.435 0.091 DBMET00051 0.363 0.136 DBMET00052 0.409 0.106 DBMET00482 | ||
| 0.423 | 0.005 | 0.423 | Histamine antagonist | 0.338 0.008 DB00540 0.206 0.018 DBMET00051 0.158 0.027 DBMET00052 0.082 0.062 DBMET00482 | ||
| 0.423 | 0.007 | 0.423 | 5 Hydroxytryptamine 2B antagonist | 0.324 0.013 DB00540 0.2 0.027 DBMET00051 0.144 0.044 DBMET00052 0.117 0.064 DBMET00482 | ||
| 0.415 | 0.003 | 0.415 | Sphingomyelinase inhibitor | 0.372 0.003 DB00540 0.285 0.004 DBMET00051 0.262 0.004 DBMET00052 0.205 0.009 DBMET00482 | ||
| 0.413 | 0.004 | 0.413 | Alpha 2c adrenoreceptor antagonist | 0.406 0.004 DB00540 0.179 0.022 DBMET00051 0.175 0.023 DBMET00052 0.107 0.059 DBMET00482 | ||
| 0.427 | 0.023 | 0.427 | Potassium channel (Voltage-sensitive) blocker | 0.256 0.064 DB00540 0.198 0.097 DBMET00051 | ||
| 0.409 | 0.005 | 0.409 | Alpha 2 adrenoreceptor antagonist | 0.4 0.005 DB00540 0.217 0.015 DBMET00051 0.212 0.016 DBMET00052 0.121 0.036 DBMET00482 | ||
| 0.395 | 0.005 | 0.503 | 5 Hydroxytryptamine uptake inhibitor | 0.503 0.004 DB00540 0.331 0.005 DBMET00051 0.428 0.005 DBMET00052 0.177 0.013 DBMET00482 | DB00540 | |
| 0.426 | 0.041 | 0.639 | 5 Hydroxytryptamine release stimulant | 0.639 0.011 DB00540 0.271 0.08 DBMET00051 0.513 0.025 DBMET00052 0.507 0.026 DBMET00482 | DB00540 | |
| 0.385 | 0.004 | 0.385 | Acetylcholine M4 receptor antagonist | 0.221 0.005 DB00540 0.138 0.013 DBMET00051 0.093 0.034 DBMET00052 0.078 0.048 DBMET00482 | ||
| 0.386 | 0.008 | 0.386 | Cholinergic antagonist | 0.317 0.013 DB00540 0.386 0.008 DBMET00051 0.317 0.013 DBMET00052 0.263 0.019 DBMET00482 | ||
| 0.369 | 0.011 | 0.369 | 5 Hydroxytryptamine 2 antagonist | 0.333 0.014 DB00540 0.138 0.049 DBMET00051 0.122 0.058 DBMET00052 | ||
| 0.357 | 0.004 | 0.357 | 5 Hydroxytryptamine 1D antagonist | 0.265 0.005 DB00540 0.113 0.018 DBMET00051 0.078 0.032 DBMET00052 | ||
| 0.362 | 0.009 | 0.362 | Acetylcholine antagonist | 0.295 0.014 DB00540 0.332 0.011 DBMET00051 0.269 0.017 DBMET00052 0.23 0.024 DBMET00482 | ||
| 0.351 | 0.006 | 0.351 | Acetylcholine muscarinic antagonist | 0.27 0.012 DB00540 0.344 0.006 DBMET00051 0.264 0.013 DBMET00052 0.232 0.018 DBMET00482 | ||
| 0.385 | 0.04 | 0.393 | Vasodilator, coronary | 0.349 0.056 DB00540 0.393 0.038 DBMET00051 0.356 0.052 DBMET00052 0.305 0.083 DBMET00482 | DBMET00051 | |
| 0.347 | 0.01 | 0.359 | Adenylate cyclase inhibitor | 0.315 0.012 DB00540 0.326 0.011 DBMET00051 0.298 0.014 DBMET00052 0.359 0.009 DBMET00482 | DBMET00482 | |
| 0.358 | 0.03 | 0.358 | Potassium channel blocker | 0.187 0.101 DB00540 0.234 0.074 DBMET00051 | ||
| 0.392 | 0.065 | 0.579 | Transcription factor NF kappa B inhibitor | 0.441 0.055 DB00540 0.525 0.041 DBMET00051 0.573 0.035 DBMET00052 0.579 0.034 DBMET00482 | DBMET00482 | |
| 0.327 | 0.005 | 0.327 | Dopamine D1 antagonist | 0.244 0.008 DB00540 0.158 0.014 DBMET00051 0.111 0.022 DBMET00052 0.075 0.036 DBMET00482 | ||
| 0.316 | 0.005 | 0.316 | 5 Hydroxytryptamine 1B antagonist | 0.249 0.006 DB00540 0.089 0.029 DBMET00051 0.067 0.043 DBMET00052 | ||
| 0.32 | 0.01 | 0.32 | 5 Hydroxytryptamine 2A antagonist | 0.267 0.013 DB00540 0.095 0.05 DBMET00051 0.075 0.063 DBMET00052 | ||
| 0.317 | 0.008 | 0.317 | 5 Hydroxytryptamine 2C antagonist | 0.28 0.01 DB00540 0.123 0.035 DBMET00051 0.106 0.042 DBMET00052 | ||
| 0.313 | 0.004 | 0.491 | Adrenaline uptake inhibitor | 0.491 0.003 DB00540 0.313 0.004 DBMET00051 0.453 0.004 DBMET00052 0.229 0.005 DBMET00482 | DB00540 | |
| 0.32 | 0.017 | 0.32 | 5 Hydroxytryptamine antagonist | 0.265 0.023 DB00540 0.139 0.054 DBMET00051 0.111 0.07 DBMET00052 | ||
| 0.314 | 0.013 | 0.314 | Antiadrenergic | 0.311 0.013 DB00540 0.179 0.029 DBMET00051 0.184 0.028 DBMET00052 0.112 0.049 DBMET00482 | ||
| 0.401 | 0.1 | 0.484 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.484 0.041 DB00540 0.355 0.145 DBMET00052 | DB00540 | |
| 0.307 | 0.013 | 0.307 | Antipruritic | 0.307 0.013 DB00540 0.215 0.04 DBMET00051 0.215 0.04 DBMET00052 0.214 0.04 DBMET00482 | ||
| 0.368 | 0.076 | 0.387 | GABA C receptor rho-3 antagonist | 0.387 0.067 DB00540 0.204 0.202 DBMET00052 0.231 0.173 DBMET00482 | DB00540 | |
| 0.306 | 0.015 | 0.306 | Alpha adrenoreceptor antagonist | 0.293 0.016 DB00540 0.167 0.033 DBMET00051 0.16 0.035 DBMET00052 0.077 0.075 DBMET00482 | ||
| 0.299 | 0.013 | 0.299 | Acetylcholinesterase inhibitor | 0.209 0.031 DB00540 0.249 0.021 DBMET00051 0.181 0.039 DBMET00052 0.112 0.087 DBMET00482 | ||
| 0.301 | 0.018 | 0.301 | Cholinergic | 0.213 0.041 DB00540 0.275 0.023 DBMET00051 0.21 0.042 DBMET00052 0.118 0.11 DBMET00482 | ||
| 0.288 | 0.006 | 0.29 | 5 Hydroxytryptamine 3E antagonist | 0.29 0.006 DB00540 0.194 0.074 DBMET00051 0.195 0.071 DBMET00052 0.182 0.101 DBMET00482 | DB00540 | |
| 0.289 | 0.014 | 0.289 | Adrenaline antagonist | 0.285 0.014 DB00540 0.165 0.031 DBMET00051 0.169 0.03 DBMET00052 0.101 0.053 DBMET00482 | ||
| 0.301 | 0.029 | 0.313 | 5 Hydroxytryptamine 1E antagonist | 0.313 0.022 DB00540 0.185 0.148 DBMET00052 | DB00540 | |
| 0.283 | 0.011 | 0.283 | 5 Hydroxytryptamine 1 antagonist | 0.208 0.016 DB00540 0.111 0.033 DBMET00051 0.081 0.047 DBMET00052 | ||
| 0.289 | 0.016 | 0.289 | Cytokine production inhibitor | 0.179 0.044 DB00540 0.113 0.097 DBMET00051 | ||
| 0.288 | 0.039 | 0.288 | Platelet aggregation inhibitor | 0.227 0.064 DB00540 0.162 0.115 DBMET00051 | ||
| 0.322 | 0.075 | 0.345 | Antithrombotic | 0.345 0.066 DB00540 0.291 0.094 DBMET00051 0.307 0.083 DBMET00052 0.34 0.068 DBMET00482 | DB00540 | |
| 0.257 | 0.012 | 0.257 | ATPase inhibitor | 0.247 0.014 DB00540 0.252 0.013 DBMET00051 0.242 0.016 DBMET00052 0.168 0.073 DBMET00482 | ||
| 0.245 | 0.004 | 0.245 | Acetylcholine M5 receptor antagonist | 0.187 0.005 DB00540 0.134 0.01 DBMET00051 0.099 0.018 DBMET00052 0.065 0.036 DBMET00482 | ||
| 0.245 | 0.005 | 0.245 | Acetylcholine M2 receptor antagonist | 0.162 0.01 DB00540 0.126 0.015 DBMET00051 0.082 0.028 DBMET00052 0.07 0.037 DBMET00482 | ||
| 0.278 | 0.045 | 0.287 | Tyrosine 3 hydroxylase inhibitor | 0.287 0.04 DB00540 0.214 0.112 DBMET00051 0.221 0.102 DBMET00052 0.275 0.048 DBMET00482 | DB00540 | |
| 0.234 | 0.005 | 0.234 | Prolactin inhibitor | 0.145 0.024 DB00540 0.156 0.02 DBMET00051 0.083 0.077 DBMET00052 0.089 0.067 DBMET00482 | ||
| 0.239 | 0.011 | 0.259 | Alpha 1b adrenoreceptor antagonist | 0.259 0.009 DB00540 | DB00540 | |
| 0.288 | 0.062 | 0.288 | DNA damaging | 0.259 0.075 DB00540 0.243 0.084 DBMET00051 0.218 0.102 DBMET00052 0.269 0.071 DBMET00482 | ||
| 0.283 | 0.059 | 0.349 | Platelet antagonist | 0.28 0.06 DB00540 0.269 0.064 DBMET00051 0.267 0.065 DBMET00052 0.349 0.038 DBMET00482 | DBMET00482 | |
| 0.236 | 0.011 | 0.24 | Nav1.4 sodium channel blocker | 0.231 0.012 DB00540 0.197 0.02 DBMET00051 0.193 0.021 DBMET00052 0.24 0.01 DBMET00482 | DBMET00482 | |
| 0.221 | 0.005 | 0.248 | Acetylcholine M3 receptor antagonist | 0.177 0.008 DB00540 0.248 0.005 DBMET00051 0.201 0.007 DBMET00052 0.151 0.011 DBMET00482 | DBMET00051 | |
| 0.227 | 0.011 | 0.227 | Mediator release inhibitor | 0.19 0.016 DB00540 0.183 0.018 DBMET00051 0.158 0.025 DBMET00052 0.174 0.02 DBMET00482 | ||
| 0.245 | 0.032 | 0.245 | RET inhibitor | 0.239 0.033 DB00540 0.151 0.061 DBMET00051 0.152 0.06 DBMET00052 0.13 0.072 DBMET00482 | ||
| 0.217 | 0.013 | 0.217 | 5 Hydroxytryptamine 1A antagonist | 0.152 0.02 DB00540 0.093 0.035 DBMET00051 0.064 0.049 DBMET00052 | ||
| 0.209 | 0.005 | 0.261 | Histamine H2 receptor antagonist | 0.261 0.004 DB00540 0.09 0.046 DBMET00051 0.108 0.028 DBMET00052 | DB00540 | |
| 0.212 | 0.009 | 0.22 | Alpha 1d adrenoreceptor antagonist | 0.22 0.008 DB00540 | DB00540 | |
| 0.224 | 0.022 | 0.224 | Calcium channel blocker | 0.165 0.048 DB00540 0.136 0.071 DBMET00051 | ||
| 0.206 | 0.005 | 0.206 | Histamine N-methyltransferase inhibitor | 0.144 0.016 DB00540 0.138 0.019 DBMET00051 0.083 0.064 DBMET00052 0.108 0.039 DBMET00482 | ||
| 0.27 | 0.073 | 0.27 | Ca(v)3.3 blocker | 0.205 0.182 DB00540 | ||
| 0.215 | 0.019 | 0.215 | Alpha 1 adrenoreceptor antagonist | 0.206 0.02 DB00540 0.103 0.042 DBMET00051 0.096 0.045 DBMET00052 | ||
| 0.206 | 0.011 | 0.232 | Adenylate cyclase stimulant | 0.224 0.006 DB00540 0.213 0.009 DBMET00051 0.232 0.005 DBMET00052 0.228 0.005 DBMET00482 | DBMET00052 | |
| 0.2 | 0.008 | 0.2 | Beta tubulin antagonist | 0.2 0.008 DB00540 0.188 0.009 DBMET00051 0.188 0.008 DBMET00052 0.166 0.01 DBMET00482 | ||
| 0.337 | 0.147 | 0.497 | Apoptosis agonist | 0.319 0.159 DB00540 0.497 0.075 DBMET00051 0.477 0.082 DBMET00052 0.446 0.093 DBMET00482 | DBMET00051 | |
| 0.247 | 0.06 | 0.349 | Antimitotic | 0.159 0.113 DB00540 0.323 0.039 DBMET00051 0.244 0.062 DBMET00052 0.349 0.032 DBMET00482 | DBMET00482 | |
| 0.204 | 0.018 | 0.204 | Dopamine antagonist | 0.157 0.024 DB00540 0.065 0.059 DBMET00051 | ||
| 0.202 | 0.021 | 0.202 | Butyrylcholinesterase inhibitor | 0.097 0.064 DB00540 0.086 0.075 DBMET00051 | ||
| 0.191 | 0.011 | 0.191 | Dopamine D3 antagonist | 0.149 0.015 DB00540 | ||
| 0.195 | 0.017 | 0.195 | Alpha 1a adrenoreceptor antagonist | 0.195 0.017 DB00540 0.086 0.042 DBMET00051 0.086 0.042 DBMET00052 | ||
| 0.184 | 0.007 | 0.258 | Dopamine uptake inhibitor | 0.171 0.008 DB00540 0.258 0.005 DBMET00051 0.239 0.005 DBMET00052 0.138 0.011 DBMET00482 | DBMET00051 | |
| 0.25 | 0.08 | 0.274 | 5 Hydroxytryptamine uptake stimulant | 0.255 0.076 DB00540 0.206 0.14 DBMET00051 0.21 0.134 DBMET00052 0.274 0.06 DBMET00482 | DBMET00482 | |
| 0.191 | 0.023 | 0.191 | Nav1.6 sodium channel blocker | 0.163 0.041 DB00540 | ||
| 0.236 | 0.071 | 0.236 | Cyclic AMP phosphodiesterase inhibitor | 0.153 0.146 DBMET00051 | ||
| 0.193 | 0.031 | 0.221 | Neurotrophic factor | 0.137 0.072 DB00540 0.221 0.019 DBMET00051 0.178 0.039 DBMET00052 0.181 0.037 DBMET00482 | DBMET00051 | |
| 0.19 | 0.029 | 0.203 | DNA intercalator | 0.203 0.025 DBMET00051 0.098 0.076 DBMET00052 | DBMET00051 | |
| 0.168 | 0.008 | 0.168 | Calcium channel L-type blocker | 0.124 0.015 DB00540 0.102 0.024 DBMET00051 0.074 0.046 DBMET00052 | ||
| 0.161 | 0.004 | 0.161 | 5 Hydroxytryptamine 3B antagonist | 0.105 0.005 DB00540 0.041 0.02 DBMET00051 | ||
| 0.172 | 0.017 | 0.172 | Calcium antagonist | 0.08 0.064 DB00540 0.082 0.062 DBMET00051 | ||
| 0.242 | 0.088 | 0.285 | Cardiotonic | 0.285 0.063 DBMET00051 0.199 0.12 DBMET00052 | DBMET00051 | |
| 0.174 | 0.02 | 0.184 | GABA C receptor antagonist | 0.161 0.025 DB00540 0.116 0.057 DBMET00051 0.107 0.068 DBMET00052 0.184 0.017 DBMET00482 | DBMET00482 | |
| 0.173 | 0.019 | 0.173 | Dopamine D2 antagonist | 0.116 0.028 DB00540 | ||
| 0.204 | 0.054 | 0.204 | Lipocortins synthesis antagonist | 0.182 0.069 DB00540 0.191 0.062 DBMET00051 0.175 0.076 DBMET00052 0.173 0.078 DBMET00482 | ||
| 0.171 | 0.021 | 0.171 | Photosensitizer | 0.107 0.076 DB00540 0.14 0.038 DBMET00051 0.111 0.07 DBMET00482 | ||
| 0.151 | 0.006 | 0.151 | 5 Hydroxytryptamine 6 antagonist | 0.121 0.01 DB00540 0.066 0.032 DBMET00051 | ||
| 0.163 | 0.021 | 0.224 | Gastric antisecretory | 0.161 0.022 DB00540 0.224 0.009 DBMET00051 0.221 0.009 DBMET00052 0.135 0.034 DBMET00482 | DBMET00051 | |
| 0.147 | 0.006 | 0.158 | Beta 3 adrenoreceptor antagonist | 0.158 0.005 DB00540 0.126 0.009 DBMET00051 0.134 0.007 DBMET00052 0.08 0.023 DBMET00482 | DB00540 | |
| 0.155 | 0.017 | 0.155 | Dopamine D4 antagonist | 0.086 0.03 DB00540 | ||
| 0.224 | 0.086 | 0.229 | Vasodilator | 0.169 0.132 DB00540 0.229 0.083 DBMET00051 0.187 0.115 DBMET00052 | DBMET00051 | |
| 0.225 | 0.089 | 0.261 | DNA synthesis inhibitor | 0.19 0.138 DB00540 0.261 0.06 DBMET00051 0.221 0.093 DBMET00052 0.244 0.07 DBMET00482 | DBMET00051 | |
| 0.221 | 0.087 | 0.221 | Neuropeptide Y2 antagonist | 0.189 0.14 DB00540 | ||
| 0.158 | 0.023 | 0.185 | Nav1.5 sodium channel blocker | 0.185 0.015 DB00540 0.104 0.078 DBMET00052 0.1 0.085 DBMET00482 | DB00540 | |
| 0.239 | 0.107 | 0.261 | Insulysin inhibitor | 0.261 0.087 DB00540 | DB00540 | |
| 0.166 | 0.036 | 0.214 | Topoisomerase I inhibitor | 0.214 0.023 DBMET00051 0.128 0.051 DBMET00052 0.169 0.035 DBMET00482 | DBMET00051 | |
| 0.253 | 0.123 | 0.3 | Cholesterol antagonist | 0.199 0.165 DB00540 0.3 0.091 DBMET00051 0.25 0.125 DBMET00052 0.251 0.124 DBMET00482 | DBMET00051 | |
| 0.201 | 0.071 | 0.219 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.219 0.058 DBMET00051 0.176 0.098 DBMET00482 | DBMET00051 | |
| 0.135 | 0.005 | 0.135 | Kinesin antagonist | 0.063 0.013 DB00540 0.045 0.018 DBMET00051 0.121 0.005 DBMET00482 | ||
| 0.135 | 0.005 | 0.135 | Kinesin-like protein 1 inhibitor | 0.063 0.013 DB00540 0.045 0.018 DBMET00051 0.121 0.005 DBMET00482 | ||
| 0.182 | 0.052 | 0.182 | Arachidonic acid antagonist | 0.126 0.118 DB00540 0.181 0.053 DBMET00051 0.125 0.12 DBMET00052 0.146 0.093 DBMET00482 | ||
| 0.144 | 0.016 | 0.145 | Dopamine agonist | 0.145 0.016 DB00540 0.059 0.053 DBMET00052 | DB00540 | |
| 0.156 | 0.033 | 0.156 | Heat shock protein 70 antagonist | 0.142 0.069 DB00540 0.145 0.058 DBMET00051 0.132 0.111 DBMET00052 0.15 0.044 DBMET00482 | ||
| 0.133 | 0.011 | 0.133 | 5 Hydroxytryptamine 3 antagonist | 0.083 0.023 DB00540 0.052 0.046 DBMET00051 | ||
| 0.154 | 0.032 | 0.154 | Calcium channel (voltage-sensitive) blocker | 0.121 0.055 DB00540 | ||
| 0.132 | 0.013 | 0.132 | Protein kinase C alpha inhibitor | 0.102 0.022 DB00540 0.085 0.03 DBMET00051 0.069 0.045 DBMET00052 0.091 0.026 DBMET00482 | ||
| 0.256 | 0.14 | 0.358 | Calcium channel activator | 0.358 0.045 DB00540 0.237 0.163 DBMET00051 0.342 0.055 DBMET00052 0.293 0.099 DBMET00482 | DB00540 | |
| 0.139 | 0.024 | 0.149 | Alcohol dehydrogenase inhibitor | 0.116 0.037 DB00540 0.123 0.033 DBMET00051 0.102 0.05 DBMET00052 0.149 0.021 DBMET00482 | DBMET00482 | |
| 0.123 | 0.009 | 0.123 | Estrogen-related receptor beta agonist | 0.097 0.028 DB00540 0.111 0.014 DBMET00051 0.089 0.043 DBMET00052 0.08 0.068 DBMET00482 | ||
| 0.148 | 0.034 | 0.148 | Nav1.1 sodium channel blocker | 0.124 0.045 DB00540 | ||
| 0.225 | 0.111 | 0.261 | Gastrin inhibitor | 0.261 0.067 DB00540 0.2 0.149 DBMET00051 0.238 0.094 DBMET00052 | DB00540 | |
| 0.127 | 0.014 | 0.146 | Glycine receptor antagonist | 0.104 0.029 DB00540 0.146 0.008 DBMET00051 0.122 0.017 DBMET00052 0.112 0.023 DBMET00482 | DBMET00051 | |
| 0.114 | 0.005 | 0.114 | Bcl-xL inhibitor | 0.071 0.019 DBMET00051 | ||
| 0.143 | 0.037 | 0.358 | GABA C receptor agonist | 0.153 0.033 DB00540 0.095 0.073 DBMET00051 0.101 0.065 DBMET00052 0.358 0.006 DBMET00482 | DBMET00482 | |
| 0.161 | 0.056 | 0.17 | Toll-Like receptor 9 antagonist | 0.17 0.051 DB00540 | DB00540 | |
| 0.135 | 0.03 | 0.188 | Nitric-oxide synthase inhibitor | 0.188 0.012 DB00540 0.12 0.038 DBMET00052 0.119 0.039 DBMET00482 | DB00540 | |
| 0.112 | 0.008 | 0.124 | Opioid kappa receptor agonist | 0.082 0.012 DB00540 0.124 0.007 DBMET00051 0.097 0.01 DBMET00052 0.124 0.007 DBMET00482 | DBMET00482 | |
| 0.188 | 0.084 | 0.188 | Amyloid beta aggregation inhibitor | 0.176 0.091 DBMET00051 0.13 0.125 DBMET00052 0.148 0.109 DBMET00482 | ||
| 0.106 | 0.005 | 0.106 | 5 Hydroxytryptamine 4 antagonist | 0.101 0.006 DB00540 0.072 0.016 DBMET00051 0.067 0.019 DBMET00052 0.063 0.021 DBMET00482 | ||
| 0.157 | 0.057 | 0.157 | MAO inhibitor | 0.116 0.077 DB00540 | ||
| 0.103 | 0.004 | 0.103 | Adenylate cyclase 1 inhibitor | 0.09 0.005 DB00540 0.093 0.005 DBMET00051 0.076 0.009 DBMET00052 0.075 0.01 DBMET00482 | ||
| 0.147 | 0.049 | 0.154 | Ca2+-transporting ATPase inhibitor | 0.138 0.08 DB00540 0.152 0.038 DBMET00051 0.143 0.063 DBMET00052 0.154 0.034 DBMET00482 | DBMET00482 | |
| 0.107 | 0.009 | 0.107 | Dopamine D5 antagonist | 0.049 0.026 DB00540 0.037 0.035 DBMET00051 | ||
| 0.153 | 0.056 | 0.18 | Sodium channel blocker | 0.18 0.041 DB00540 | DB00540 | |
| 0.169 | 0.075 | 0.222 | Phospholipase C inhibitor | 0.138 0.132 DB00540 0.178 0.063 DBMET00051 0.147 0.113 DBMET00052 0.222 0.033 DBMET00482 | DBMET00482 | |
| 0.13 | 0.038 | 0.145 | Estrogen antagonist | 0.113 0.068 DB00540 0.145 0.025 DBMET00051 0.129 0.039 DBMET00052 0.128 0.042 DBMET00482 | DBMET00051 | |
| 0.149 | 0.058 | 0.151 | Tubulin antagonist | 0.133 0.068 DB00540 0.151 0.057 DBMET00051 0.138 0.064 DBMET00052 0.143 0.061 DBMET00482 | DBMET00051 | |
| 0.104 | 0.016 | 0.104 | Sigma receptor antagonist | 0.051 0.034 DB00540 | ||
| 0.1 | 0.015 | 0.107 | Androgen agonist | 0.08 0.024 DB00540 0.107 0.013 DBMET00051 0.087 0.02 DBMET00052 0.088 0.02 DBMET00482 | DBMET00051 | |
| 0.193 | 0.111 | 0.194 | RNA-directed DNA polymerase inhibitor | 0.183 0.128 DBMET00051 0.194 0.108 DBMET00482 | DBMET00482 | |
| 0.098 | 0.017 | 0.108 | Acyl-CoA dehydrogenase inhibitor | 0.057 0.035 DB00540 0.108 0.015 DBMET00051 0.063 0.031 DBMET00052 0.064 0.03 DBMET00482 | DBMET00051 | |
| 0.129 | 0.048 | 0.129 | Falcipain 3 inhibitor | 0.089 0.083 DB00540 | ||
| 0.152 | 0.071 | 0.199 | GABA C receptor rho-2 antagonist | 0.199 0.029 DB00540 | DB00540 | |
| 0.109 | 0.029 | 0.109 | Telomerase inhibitor | 0.086 0.041 DBMET00051 | ||
| 0.12 | 0.041 | 0.177 | Creatine kinase inhibitor | 0.103 0.056 DB00540 0.131 0.033 DBMET00051 0.113 0.046 DBMET00052 0.177 0.015 DBMET00482 | DBMET00482 | |
| 0.105 | 0.029 | 0.116 | Analgesic, opioid | 0.089 0.038 DB00540 0.116 0.024 DBMET00051 0.101 0.031 DBMET00052 0.1 0.031 DBMET00482 | DBMET00051 | |
| 0.117 | 0.042 | 0.135 | Anabolic | 0.108 0.053 DB00540 0.131 0.03 DBMET00051 0.122 0.038 DBMET00052 0.135 0.027 DBMET00482 | DBMET00482 | |
| 0.085 | 0.01 | 0.085 | Potassium channel (Inward rectifier) blocker | 0.071 0.017 DB00540 0.055 0.028 DBMET00051 0.044 0.043 DBMET00052 | ||
| 0.083 | 0.009 | 0.083 | Squalene epoxidase inhibitor | 0.066 0.016 DB00540 0.075 0.011 DBMET00051 0.061 0.02 DBMET00052 0.053 0.029 DBMET00482 | ||
| 0.131 | 0.059 | 0.162 | Papain-like protease (SARS coronavirus) inhibitor | 0.162 0.025 DB00540 0.12 0.082 DBMET00051 0.144 0.04 DBMET00052 0.129 0.063 DBMET00482 | DB00540 | |
| 0.112 | 0.042 | 0.112 | Ca(v)2.2 blocker | 0.081 0.064 DB00540 | ||
| 0.136 | 0.066 | 0.168 | Sodium channel (voltage-gated) blocker | 0.168 0.043 DB00540 | DB00540 | |
| 0.091 | 0.021 | 0.091 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.086 0.027 DB00540 0.072 0.055 DBMET00051 0.085 0.029 DBMET00482 | ||
| 0.091 | 0.021 | 0.14 | Beta adrenoreceptor antagonist | 0.116 0.011 DB00540 0.113 0.012 DBMET00051 0.14 0.007 DBMET00052 0.106 0.014 DBMET00482 | DBMET00052 | |
| 0.119 | 0.049 | 0.125 | Acetylcholine release stimulant | 0.125 0.041 DB00540 | DB00540 | |
| 0.085 | 0.015 | 0.11 | Beta 1 adrenoreceptor antagonist | 0.11 0.008 DB00540 0.075 0.021 DBMET00051 0.095 0.011 DBMET00052 0.066 0.029 DBMET00482 | DB00540 | |
| 0.085 | 0.015 | 0.143 | Dopamine transporter inhibitor | 0.111 0.009 DB00540 0.121 0.008 DBMET00051 0.143 0.006 DBMET00052 0.101 0.012 DBMET00482 | DBMET00052 | |
| 0.121 | 0.052 | 0.121 | Protein kinase C gamma inhibitor | 0.096 0.084 DB00540 0.119 0.053 DBMET00051 0.095 0.086 DBMET00052 0.103 0.071 DBMET00482 | ||
| 0.08 | 0.013 | 0.08 | 5 Hydroxytryptamine 7 agonist | 0.068 0.021 DB00540 | ||
| 0.078 | 0.013 | 0.09 | 5 Hydroxytryptamine 1B agonist | 0.09 0.009 DB00540 | DB00540 | |
| 0.099 | 0.036 | 0.111 | CYP2A6 inhibitor | 0.111 0.031 DB00540 0.067 0.064 DBMET00482 | DB00540 | |
| 0.093 | 0.031 | 0.093 | CC chemokine 5 receptor agonist | 0.079 0.067 DB00540 0.08 0.066 DBMET00051 | ||
| 0.076 | 0.014 | 0.079 | Nicotinic alpha3beta2 receptor antagonist | 0.079 0.013 DB00540 0.049 0.047 DBMET00052 | DB00540 | |
| 0.123 | 0.062 | 0.147 | Cholesterol synthesis inhibitor | 0.147 0.046 DBMET00051 | DBMET00051 | |
| 0.096 | 0.036 | 0.108 | Na+ K+ transporting ATPase inhibitor | 0.104 0.028 DBMET00051 0.066 0.064 DBMET00052 0.108 0.025 DBMET00482 | DBMET00482 | |
| 0.121 | 0.062 | 0.121 | Calcium channel N-type blocker | 0.11 0.077 DB00540 | ||
| 0.094 | 0.034 | 0.094 | Interferon agonist | 0.089 0.039 DBMET00051 0.084 0.046 DBMET00482 | ||
| 0.097 | 0.039 | 0.097 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.07 0.06 DBMET00051 | ||
| 0.073 | 0.015 | 0.103 | Beta 2 adrenoreceptor antagonist | 0.098 0.008 DB00540 0.076 0.014 DBMET00051 0.103 0.008 DBMET00052 0.075 0.014 DBMET00482 | DBMET00052 | |
| 0.064 | 0.006 | 0.064 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.057 0.008 DBMET00051 | ||
| 0.081 | 0.024 | 0.081 | Exportin-1 inhibitor | 0.063 0.061 DB00540 | ||
| 0.06 | 0.005 | 0.06 | Urotensin II agonist | 0.037 0.01 DBMET00051 | ||
| 0.108 | 0.052 | 0.165 | GABA C receptor rho-1 antagonist | 0.165 0.016 DB00540 0.1 0.063 DBMET00052 0.143 0.024 DBMET00482 | DB00540 | |
| 0.107 | 0.052 | 0.124 | Estrogen receptor beta antagonist | 0.09 0.083 DB00540 0.124 0.028 DBMET00051 0.114 0.04 DBMET00052 0.115 0.038 DBMET00482 | DBMET00051 | |
| 0.099 | 0.044 | 0.111 | Glutamate release inhibitor | 0.111 0.029 DB00540 0.084 0.079 DBMET00482 | DB00540 | |
| 0.061 | 0.008 | 0.079 | Histamine H1 receptor agonist | 0.079 0.004 DB00540 0.042 0.034 DBMET00052 | DB00540 | |
| 0.167 | 0.114 | 0.2 | Neurotrophic factor enhancer | 0.188 0.089 DB00540 0.179 0.099 DBMET00051 0.2 0.076 DBMET00052 0.196 0.08 DBMET00482 | DBMET00052 | |
| 0.186 | 0.134 | 0.371 | Superoxide dismutase inhibitor | 0.217 0.1 DB00540 0.174 0.15 DBMET00052 0.371 0.032 DBMET00482 | DBMET00482 | |
| 0.103 | 0.052 | 0.131 | Lanosterol 14 alpha demethylase inhibitor | 0.09 0.071 DB00540 0.106 0.046 DBMET00051 0.094 0.064 DBMET00052 0.131 0.021 DBMET00482 | DBMET00482 | |
| 0.103 | 0.053 | 0.161 | Glutamate (mGluR7) agonist | 0.161 0.009 DB00540 0.129 0.022 DBMET00052 0.096 0.068 DBMET00482 | DB00540 | |
| 0.092 | 0.044 | 0.094 | Acetylcholine nicotinic antagonist | 0.094 0.043 DB00540 | DB00540 | |
| 0.109 | 0.062 | 0.109 | Ferrochelatase inhibitor | 0.096 0.075 DB00540 0.096 0.075 DBMET00482 | ||
| 0.065 | 0.019 | 0.065 | Topoisomerase II beta inhibitor | 0.055 0.026 DBMET00051 | ||
| 0.119 | 0.074 | 0.12 | DNA repair enzyme inhibitor | 0.12 0.072 DBMET00051 | DBMET00051 | |
| 0.059 | 0.014 | 0.059 | Geranyltranstransferase inhibitor | 0.047 0.027 DB00540 0.044 0.03 DBMET00051 0.046 0.028 DBMET00482 | ||
| 0.058 | 0.013 | 0.072 | Dopamine D5 agonist | 0.059 0.012 DB00540 0.072 0.008 DBMET00482 | DBMET00482 | |
| 0.08 | 0.035 | 0.08 | Potassium channel (Tandem pore domain) blocker | 0.077 0.043 DB00540 0.078 0.038 DBMET00051 0.076 0.046 DBMET00052 0.077 0.042 DBMET00482 | ||
| 0.116 | 0.072 | 0.182 | Alkylator | 0.115 0.073 DB00540 0.182 0.032 DBMET00051 0.18 0.033 DBMET00052 0.177 0.034 DBMET00482 | DBMET00051 | |
| 0.049 | 0.005 | 0.049 | Estrogen-related receptor beta antagonist | 0.032 0.023 DB00540 0.043 0.008 DBMET00051 0.031 0.026 DBMET00052 0.032 0.023 DBMET00482 | ||
| 0.084 | 0.041 | 0.113 | GABA aminotransferase inhibitor | 0.077 0.051 DB00540 0.113 0.019 DBMET00482 | DBMET00482 | |
| 0.07 | 0.027 | 0.093 | Acetylcholine muscarinic agonist | 0.093 0.019 DBMET00051 0.048 0.045 DBMET00052 | DBMET00051 | |
| 0.068 | 0.027 | 0.068 | Prolactin release inhibitor | 0.062 0.045 DBMET00051 | ||
| 0.133 | 0.093 | 0.133 | Pregnane X receptor agonist | 0.124 0.117 DBMET00051 | ||
| 0.083 | 0.044 | 0.1 | Estrogen receptor alpha antagonist | 0.1 0.027 DBMET00051 0.072 0.064 DBMET00052 0.071 0.066 DBMET00482 | DBMET00051 | |
| 0.06 | 0.022 | 0.06 | Histamine H3 receptor antagonist | 0.045 0.03 DB00540 | ||
| 0.077 | 0.04 | 0.092 | Phospholipase D inhibitor | 0.092 0.02 DB00540 0.068 0.059 DBMET00052 | DB00540 | |
| 0.052 | 0.014 | 0.052 | GABA uptake inhibitor | 0.036 0.033 DBMET00482 | ||
| 0.178 | 0.141 | 0.328 | Interleukin agonist | 0.242 0.085 DB00540 0.197 0.124 DBMET00051 0.258 0.073 DBMET00052 0.328 0.036 DBMET00482 | DBMET00482 | |
| 0.12 | 0.084 | 0.12 | Toll-Like receptor antagonist | 0.114 0.095 DB00540 | ||
| 0.175 | 0.138 | 0.333 | Peptidyltransferase inhibitor | 0.297 0.025 DB00540 0.246 0.053 DBMET00051 0.319 0.019 DBMET00052 0.333 0.015 DBMET00482 | DBMET00482 | |
| 0.06 | 0.024 | 0.06 | Prolyl endopeptidase inhibitor | |||
| 0.099 | 0.064 | 0.099 | Chemokine receptor antagonist | |||
| 0.053 | 0.019 | 0.079 | Histamine H2 receptor agonist | 0.079 0.008 DB00540 | DB00540 | |
| 0.06 | 0.026 | 0.067 | 5 Hydroxytryptamine 2 agonist | 0.067 0.021 DB00540 | DB00540 | |
| 0.07 | 0.037 | 0.075 | 5 Hydroxytryptamine 2A agonist | 0.075 0.032 DB00540 | DB00540 | |
| 0.149 | 0.116 | 0.149 | Non-steroidal antiinflammatory agent | 0.147 0.118 DB00540 | ||
| 0.056 | 0.023 | 0.061 | Acetylcholine M1 receptor agonist | 0.061 0.021 DBMET00051 | DBMET00051 | |
| 0.06 | 0.028 | 0.061 | Epithelial sodium channel blocker | 0.061 0.027 DB00540 | DB00540 | |
| 0.043 | 0.011 | 0.069 | Melatonin receptor 1A agonist | 0.069 0.004 DB00540 | DB00540 | |
| 0.037 | 0.006 | 0.037 | Estrogen-related receptor gamma antagonist | 0.027 0.024 DB00540 0.028 0.019 DBMET00051 | ||
| 0.104 | 0.073 | 0.104 | GABA receptor agonist | 0.097 0.081 DB00540 | ||
| 0.096 | 0.067 | 0.152 | Carbonic anhydrase III inhibitor | 0.105 0.057 DBMET00051 0.152 0.028 DBMET00482 | DBMET00482 | |
| 0.087 | 0.058 | 0.089 | Acetylcholine agonist | 0.076 0.072 DB00540 0.089 0.056 DBMET00051 0.077 0.07 DBMET00052 | DBMET00051 | |
| 0.113 | 0.085 | 0.183 | Alpha-N-acetylglucosaminidase inhibitor | 0.126 0.072 DB00540 0.153 0.053 DBMET00051 0.17 0.045 DBMET00052 0.183 0.039 DBMET00482 | DBMET00482 | |
| 0.098 | 0.07 | 0.153 | Carbonic anhydrase XV inhibitor | 0.091 0.08 DBMET00051 0.153 0.029 DBMET00482 | DBMET00482 | |
| 0.049 | 0.022 | 0.049 | Guanylate cyclase inhibitor | 0.041 0.031 DBMET00051 | ||
| 0.044 | 0.017 | 0.044 | Retinoid X alpha receptor agonist | 0.034 0.025 DB00540 | ||
| 0.107 | 0.081 | 0.194 | Sphingosine 1-phosphate receptor 2 agonist | 0.194 0.012 DBMET00051 0.15 0.025 DBMET00052 0.154 0.024 DBMET00482 | DBMET00051 | |
| 0.118 | 0.093 | 0.136 | Vanilloid 1 agonist | 0.136 0.056 DB00540 0.121 0.085 DBMET00052 0.115 0.1 DBMET00482 | DB00540 | |
| 0.145 | 0.121 | 0.153 | Succinate dehydrogenase inhibitor | 0.15 0.112 DB00540 0.153 0.107 DBMET00482 | DBMET00482 | |
| 0.034 | 0.011 | 0.034 | 5 Hydroxytryptamine 6 agonist | |||
| 0.05 | 0.027 | 0.05 | Benzodiazepine antagonist | |||
| 0.027 | 0.005 | 0.027 | NMDA receptor phencyclidine site antagonist | 0.02 0.007 DB00540 0.021 0.006 DBMET00051 0.016 0.01 DBMET00052 | ||
| 0.069 | 0.046 | 0.077 | Neuronal nicotinic receptor antagonist | 0.077 0.039 DB00540 | DB00540 | |
| 0.041 | 0.019 | 0.041 | Opioid delta receptor agonist | 0.037 0.022 DB00540 0.034 0.027 DBMET00051 0.032 0.031 DBMET00052 0.04 0.019 DBMET00482 | ||
| 0.037 | 0.015 | 0.037 | 5 Hydroxytryptamine 1D agonist | 0.028 0.021 DB00540 | ||
| 0.035 | 0.014 | 0.035 | Sigma 2 receptor antagonist | |||
| 0.069 | 0.05 | 0.069 | Protein kinase C beta inhibitor | 0.066 0.056 DBMET00051 | ||
| 0.047 | 0.028 | 0.047 | Potassium channel small-conductance Ca-activated blocker | 0.045 0.031 DB00540 | ||
| 0.131 | 0.112 | 0.199 | Melanin inhibitor | 0.133 0.109 DB00540 0.149 0.082 DBMET00051 0.151 0.08 DBMET00052 0.199 0.041 DBMET00482 | DBMET00482 | |
| 0.14 | 0.122 | 0.169 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.169 0.096 DB00540 | DB00540 | |
| 0.06 | 0.042 | 0.09 | Alpha 2 adrenoreceptor agonist | 0.09 0.018 DB00540 | DB00540 | |
| 0.063 | 0.046 | 0.065 | Interferon inducer | 0.061 0.051 DBMET00051 0.065 0.043 DBMET00482 | DBMET00482 | |
| 0.06 | 0.042 | 0.06 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.053 | 0.036 | 0.085 | Opioid agonist | 0.047 0.043 DB00540 0.066 0.026 DBMET00051 0.059 0.03 DBMET00052 0.085 0.017 DBMET00482 | DBMET00482 | |
| 0.051 | 0.035 | 0.06 | Thromboxane A2 antagonist | 0.06 0.028 DB00540 | DB00540 | |
| 0.125 | 0.11 | 0.125 | Cyclin-dependent kinase 8 inhibitor | 0.123 0.113 DB00540 | ||
| 0.043 | 0.029 | 0.043 | Nerve growth factor antagonist | 0.039 0.037 DB00540 | ||
| 0.113 | 0.099 | 0.113 | Interleukin 1 antagonist | |||
| 0.062 | 0.048 | 0.062 | Calcium channel P-type blocker | |||
| 0.066 | 0.051 | 0.066 | Glutamate (mGluR7) antagonist | |||
| 0.04 | 0.026 | 0.069 | Alpha 1d adrenoreceptor agonist | 0.069 0.007 DB00540 | DB00540 | |
| 0.053 | 0.04 | 0.064 | Thromboxane synthase inhibitor | 0.064 0.023 DB00540 0.051 0.045 DBMET00052 | DB00540 | |
| 0.047 | 0.034 | 0.047 | Glycine transporter inhibitor | |||
| 0.057 | 0.044 | 0.057 | CXC chemokine 4 receptor antagonist | 0.056 0.045 DB00540 | ||
| 0.052 | 0.039 | 0.059 | Thromboxane antagonist | 0.059 0.033 DB00540 | DB00540 | |
| 0.067 | 0.055 | 0.067 | Benzodiazepine agonist | |||
| 0.037 | 0.026 | 0.046 | Delayed rectifier potassium channel blocker | 0.046 0.014 DB00540 0.041 0.02 DBMET00052 | DB00540 | |
| 0.034 | 0.023 | 0.034 | Benzodiazepine receptor peripheral-type antagonist | |||
| 0.031 | 0.02 | 0.031 | AMPA 3 receptor antagonist | 0.028 0.022 DB00540 | ||
| 0.026 | 0.015 | 0.038 | Dopamine autoreceptor agonist | 0.038 0.01 DB00540 | DB00540 | |
| 0.031 | 0.021 | 0.051 | Acetylcholine M4 receptor agonist | 0.051 0.011 DBMET00051 | DBMET00051 | |
| 0.019 | 0.009 | 0.032 | Prostacyclin agonist | 0.014 0.013 DB00540 0.032 0.005 DBMET00051 0.024 0.007 DBMET00052 0.031 0.005 DBMET00482 | DBMET00051 | |
| 0.085 | 0.075 | 0.085 | Protein kinase C zeta inhibitor | |||
| 0.1 | 0.091 | 0.1 | Interleukin 2 antagonist | |||
| 0.106 | 0.097 | 0.131 | Cathepsin H inhibitor | 0.131 0.062 DB00540 0.104 0.1 DBMET00052 0.127 0.067 DBMET00482 | DB00540 | |
| 0.053 | 0.045 | 0.064 | Immunoglobulin Fc receptor antagonist | 0.064 0.018 DB00540 | DB00540 | |
| 0.091 | 0.084 | 0.127 | Adenylate kinase inhibitor | 0.103 0.062 DBMET00051 0.1 0.068 DBMET00052 0.127 0.038 DBMET00482 | DBMET00482 | |
| 0.049 | 0.042 | 0.067 | Histamine agonist | 0.067 0.021 DB00540 | DB00540 | |
| 0.022 | 0.015 | 0.022 | Protease (Human cytomegalovirus) inhibitor | |||
| 0.08 | 0.074 | 0.097 | NADH dehydrogenase inhibitor | 0.093 0.053 DBMET00051 0.097 0.047 DBMET00482 | DBMET00482 | |
| 0.139 | 0.133 | 0.166 | Neurotensin receptor agonist | 0.166 0.069 DB00540 0.153 0.095 DBMET00482 | DB00540 | |
| 0.037 | 0.031 | 0.037 | 5 Hydroxytryptamine 2B agonist | |||
| 0.227 | 0.222 | 0.227 | MAP kinase kinase 6 inhibitor | |||
| 0.049 | 0.045 | 0.049 | Nicotinic receptor alpha7 subunit antagonist | |||
| 0.023 | 0.02 | 0.023 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.024 | 0.021 | 0.026 | Vanilloid 2 agonist | 0.026 0.017 DB00540 0.025 0.019 DBMET00052 | DB00540 | |
| 0.059 | 0.056 | 0.059 | Bcl2 antagonist | |||
| 0.036 | 0.034 | 0.047 | Histone deacetylase 9 inhibitor | 0.047 0.018 DB00540 | DB00540 | |
| 0.055 | 0.053 | 0.055 | NMDA 2C receptor antagonist | |||
| 0.036 | 0.035 | 0.036 | AMPA 4 receptor antagonist | |||
| 0.097 | 0.096 | 0.131 | Microtubule formation inhibitor | 0.103 0.086 DB00540 0.123 0.057 DBMET00051 0.131 0.05 DBMET00052 0.115 0.066 DBMET00482 | DBMET00052 | |
| 0.014 | 0.015 | 0.027 | Thromboxane A2 agonist | 0.017 0.009 DB00540 0.022 0.005 DBMET00051 0.027 0.004 DBMET00052 0.026 0.004 DBMET00482 | DBMET00052 | |
| 0.033 | 0.034 | 0.037 | Diamine oxidase inhibitor | 0.037 0.027 DB00540 | DB00540 | |
| 0.024 | 0.027 | 0.025 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.025 0.024 DBMET00051 | DBMET00051 | |
| 0.074 | 0.077 | 0.082 | Myeloperoxidase inhibitor | 0.082 0.064 DB00540 | DB00540 | |
| 0.065 | 0.068 | 0.096 | Nicotinic alpha4beta2 receptor antagonist | 0.096 0.035 DB00540 | DB00540 | |
| 0.034 | 0.037 | 0.037 | Membrane dipeptidase inhibitor | 0.037 0.03 DB00540 | DB00540 | |
| 0.014 | 0.017 | 0.015 | Antibiotic Tetracycline-like | 0.015 0.011 DBMET00051 | DBMET00051 | |
| 0.077 | 0.081 | 0.093 | Protein kinase C delta inhibitor | 0.093 0.058 DBMET00482 | DBMET00482 | |
| 0.036 | 0.04 | 0.05 | Phenylethanolamine N methyltransferase inhibitor | 0.037 0.036 DB00540 0.037 0.036 DBMET00052 0.05 0.015 DBMET00482 | DBMET00482 | |
| 0.06 | 0.067 | 0.092 | Porphobilinogen synthase inhibitor | 0.092 0.04 DBMET00482 | DBMET00482 | |
| 0.014 | 0.02 | 0.02 | Histamine H4 receptor agonist | 0.02 0.012 DB00540 | DB00540 | |
| 0.042 | 0.049 | 0.045 | Histamine H4 receptor antagonist | 0.045 0.04 DB00540 | DB00540 | |
| 0.067 | 0.074 | 0.082 | Vanilloid 4 agonist | 0.082 0.037 DB00540 0.071 0.062 DBMET00052 | DB00540 | |
| 0.054 | 0.062 | 0.071 | Sphingosine 1-phosphate receptor 4 agonist | 0.071 0.043 DB00540 | DB00540 | |
| 0.105 | 0.113 | 0.253 | Protein kinase stimulant | 0.147 0.07 DB00540 0.139 0.076 DBMET00051 0.189 0.046 DBMET00052 0.253 0.026 DBMET00482 | DBMET00482 | |
| 0.022 | 0.031 | 0.036 | Nicotinic alpha4beta2 receptor agonist | 0.036 0.011 DB00540 | DB00540 | |
| 0.063 | 0.072 | 0.171 | Glycine receptor agonist | 0.076 0.044 DBMET00051 0.171 0.005 DBMET00482 | DBMET00482 | |
| 0.043 | 0.053 | 0.048 | Aconitate hydratase inhibitor | 0.048 0.041 DBMET00482 | DBMET00482 | |
| 0.059 | 0.071 | 0.082 | Aminopeptidase I inhibitor | 0.073 0.049 DB00540 0.064 0.062 DBMET00052 0.082 0.04 DBMET00482 | DBMET00482 | |
| 0.024 | 0.038 | 0.049 | Arginase inhibitor | 0.049 0.015 DBMET00482 | DBMET00482 | |
| 0.117 | 0.131 | 0.125 | Neuropeptide Y1 antagonist | 0.125 0.11 DB00540 | DB00540 | |
| 0.023 | 0.038 | 0.029 | Hedgehog signaling activator | 0.029 0.015 DBMET00051 0.026 0.025 DBMET00482 | DBMET00051 | |
| 0.029 | 0.045 | 0.04 | Histone deacetylase 8 inhibitor | 0.04 0.03 DB00540 | DB00540 | |
| 0.022 | 0.039 | 0.026 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.026 0.023 DB00540 | DB00540 | |
| 0.065 | 0.082 | 0.127 | Carbonic anhydrase VI inhibitor | 0.127 0.027 DBMET00482 | DBMET00482 | |
| 0.083 | 0.101 | 0.107 | 5 Hydroxytryptamine 3A agonist | 0.107 0.068 DB00540 | DB00540 | |
| 0.025 | 0.044 | 0.033 | NMDA receptor subunit 3A antagonist | 0.033 0.032 DBMET00482 | DBMET00482 | |
| 0.009 | 0.029 | 0.018 | Melatonin receptor 1A antagonist | 0.018 0.006 DB00540 | DB00540 | |
| 0.034 | 0.055 | 0.044 | Kainate receptor agonist | 0.044 0.022 DBMET00482 | DBMET00482 | |
| 0.062 | 0.084 | 0.074 | Acetylcholine nicotinic agonist | 0.074 0.065 DB00540 | DB00540 | |
| 0.066 | 0.089 | 0.103 | Antineoplastic alkaloid | 0.103 0.045 DBMET00051 | DBMET00051 | |
| 0.005 | 0.029 | 0.012 | Thromboxane agonist | 0.01 0.008 DBMET00051 0.01 0.008 DBMET00052 0.012 0.006 DBMET00482 | DBMET00482 | |
| 0.019 | 0.045 | 0.031 | Sirtuin 2 inhibitor | 0.031 0.025 DB00540 | DB00540 | |
| 0.019 | 0.046 | 0.028 | Prostaglandin D2 agonist | 0.028 0.025 DBMET00482 | DBMET00482 | |
| 0.056 | 0.084 | 0.125 | Glutamate dehydrogenase inhibitor | 0.07 0.056 DBMET00052 0.125 0.021 DBMET00482 | DBMET00482 | |
| 0.069 | 0.097 | 0.104 | HIV-1 integrase (Overall Integration) inhibitor | 0.104 0.051 DBMET00482 | DBMET00482 | |
| 0.056 | 0.085 | 0.075 | Glutamate (mGluR6) antagonist | 0.075 0.03 DBMET00482 | DBMET00482 | |
| 0.08 | 0.109 | 0.093 | Phosphodiesterase 6D inhibitor | 0.093 0.068 DBMET00051 | DBMET00051 | |
| 0.011 | 0.04 | 0.022 | Alpha 2c adrenoreceptor agonist | 0.022 0.009 DB00540 | DB00540 | |
| 0.136 | 0.167 | 0.255 | Immunostimulant | 0.187 0.128 DBMET00051 0.159 0.147 DBMET00052 0.255 0.094 DBMET00482 | DBMET00482 | |
| 0.018 | 0.049 | 0.023 | Glutamate (mGluR1) agonist | 0.023 0.021 DB00540 | DB00540 | |
| 0.025 | 0.057 | 0.037 | Ceramide glucosyltransferase inhibitor | 0.034 0.027 DBMET00051 0.037 0.021 DBMET00052 | DBMET00052 | |
| 0.036 | 0.068 | 0.046 | Glucose-6-phosphate isomerase inhibitor | 0.046 0.036 DBMET00482 | DBMET00482 | |
| 0.021 | 0.053 | 0.042 | Melatonin agonist | 0.042 0.013 DB00540 | DB00540 | |
| 0.066 | 0.099 | 0.134 | Aminopeptidase B inhibitor | 0.086 0.076 DB00540 0.134 0.045 DBMET00482 | DBMET00482 | |
| 0.046 | 0.08 | 0.073 | NMDA receptor agonist | 0.073 0.033 DB00540 | DB00540 | |
| 0.017 | 0.051 | 0.031 | Endothelial nitric-oxide synthase inhibitor | 0.031 0.021 DB00540 | DB00540 | |
| 0.03 | 0.065 | 0.039 | Plasmepsin II inhibitor | 0.039 0.033 DBMET00482 | DBMET00482 | |
| 0.04 | 0.075 | 0.091 | Carbamoyl phosphate synthetase inhibitor | 0.091 0.024 DBMET00482 | DBMET00482 | |
| 0.02 | 0.055 | 0.045 | Melatonin 2 agonist | 0.045 0.013 DB00540 | DB00540 | |
| 0.051 | 0.086 | 0.059 | Heme oxygenase stimulant | 0.059 0.049 DB00540 | DB00540 | |
| 0.052 | 0.087 | 0.113 | Glutamate decarboxylase inhibitor | 0.113 0.023 DBMET00482 | DBMET00482 | |
| 0.047 | 0.082 | 0.079 | Alpha adrenoreceptor agonist | 0.079 0.038 DB00540 | DB00540 | |
| 0.04 | 0.077 | 0.047 | Factor III inhibitor | 0.047 0.042 DBMET00482 | DBMET00482 | |
| 0.114 | 0.151 | 0.136 | Interferon gamma antagonist | 0.129 0.114 DBMET00051 0.125 0.121 DBMET00052 0.136 0.099 DBMET00482 | DBMET00482 | |
| 0.095 | 0.134 | 0.121 | Peroxidase inhibitor | 0.121 0.099 DBMET00482 | DBMET00482 | |
| 0.012 | 0.052 | 0.025 | Antibiotic Anthracycline-like | 0.02 0.012 DBMET00051 0.019 0.014 DBMET00052 0.025 0.005 DBMET00482 | DBMET00482 | |
| 0.062 | 0.103 | 0.107 | Inducible nitric-oxide synthase inhibitor | 0.107 0.031 DB00540 0.082 0.059 DBMET00052 0.082 0.059 DBMET00482 | DB00540 | |
| 0.045 | 0.087 | 0.1 | Phenylalanine 4-hydroxylase inhibitor | 0.076 0.041 DB00540 0.067 0.049 DBMET00052 0.1 0.025 DBMET00482 | DBMET00482 | |
| 0.059 | 0.102 | 0.075 | Opioid kappa receptor antagonist | 0.075 0.066 DB00540 | DB00540 | |
| 0.045 | 0.089 | 0.058 | Histone deacetylase inhibitor | 0.058 0.057 DB00540 | DB00540 | |
| 0.037 | 0.081 | 0.072 | Biliverdin reductase inhibitor | 0.072 0.031 DBMET00482 | DBMET00482 | |
| 0.066 | 0.11 | 0.098 | Triose-phosphate isomerase inhibitor | 0.098 0.05 DBMET00482 | DBMET00482 | |
| 0.087 | 0.131 | 0.151 | Toll-Like receptor 2 antagonist | 0.106 0.095 DB00540 0.151 0.052 DBMET00482 | DBMET00482 | |
| 0.008 | 0.053 | 0.019 | Alpha 2a adrenoreceptor agonist | 0.019 0.01 DB00540 | DB00540 | |
| 0.02 | 0.065 | 0.039 | Melatonin 1 agonist | 0.039 0.016 DB00540 | DB00540 | |
| 0.018 | 0.065 | 0.037 | Purinergic P2Y15 antagonist | 0.031 0.015 DBMET00052 0.037 0.009 DBMET00482 | DBMET00482 | |
| 0.087 | 0.135 | 0.127 | Lipid peroxidase inhibitor | 0.127 0.087 DBMET00051 | DBMET00051 | |
| 0.21 | 0.257 | 0.573 | Calcium channel L-type activator | 0.573 0.009 DB00540 0.51 0.024 DBMET00052 | DB00540 | |
| 0.064 | 0.112 | 0.08 | MAP kinase kinase 7 inhibitor | 0.08 0.047 DBMET00482 | DBMET00482 | |
| 0.05 | 0.099 | 0.066 | Histone deacetylase SIRT3 inhibitor | 0.066 0.034 DB00540 | DB00540 | |
| 0.039 | 0.089 | 0.087 | Phosphofructokinase-1 inhibitor | 0.087 0.037 DBMET00482 | DBMET00482 | |
| 0.086 | 0.138 | 0.105 | Interleukin 8 antagonist | 0.105 0.086 DB00540 | DB00540 | |
| 0.014 | 0.068 | 0.033 | Prostaglandin agonist | 0.028 0.025 DBMET00051 0.033 0.018 DBMET00482 | DBMET00482 | |
| 0.008 | 0.063 | 0.017 | Melatonin 1 antagonist | 0.017 0.016 DB00540 | DB00540 | |
| 0.02 | 0.075 | 0.05 | Estrogen agonist | 0.05 0.035 DBMET00051 | DBMET00051 | |
| 0.031 | 0.087 | 0.148 | Alcohol oxidase inhibitor | 0.148 0.01 DBMET00482 | DBMET00482 | |
| 0.052 | 0.108 | 0.13 | Ornithine decarboxylase inhibitor | 0.101 0.043 DB00540 0.103 0.041 DBMET00052 0.13 0.019 DBMET00482 | DBMET00482 | |
| 0.035 | 0.092 | 0.055 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.055 0.04 DBMET00482 | DBMET00482 | |
| 0.016 | 0.073 | 0.031 | Fumarate hydratase inhibitor | 0.031 0.028 DBMET00482 | DBMET00482 | |
| 0.218 | 0.276 | 0.249 | 5 Hydroxytryptamine release inhibitor | 0.249 0.229 DBMET00482 | DBMET00482 | |
| 0.006 | 0.067 | 0.019 | KiSS-1 receptor antagonist | 0.019 0.01 DB00540 | DB00540 | |
| 0.05 | 0.112 | 0.059 | Beta 2 adrenoreceptor agonist | 0.059 0.055 DBMET00052 | DBMET00052 | |
| 0.011 | 0.073 | 0.028 | Melatonin antagonist | 0.028 0.019 DB00540 | DB00540 | |
| 0.017 | 0.08 | 0.026 | Thrombin receptor antagonist | 0.026 0.023 DB00540 | DB00540 | |
| 0.038 | 0.101 | 0.05 | Glucosylceramidase inhibitor | 0.05 0.047 DBMET00052 | DBMET00052 | |
| 0.021 | 0.085 | 0.055 | NMDA 2A receptor antagonist | 0.055 0.033 DB00540 | DB00540 | |
| 0.033 | 0.097 | 0.055 | Alpha-mannosidase inhibitor | 0.055 0.034 DBMET00052 0.055 0.034 DBMET00482 | DBMET00482 | |
| 0.063 | 0.129 | 0.091 | UDP-glucose 4-epimerase inhibitor | 0.091 0.072 DBMET00482 | DBMET00482 | |
| 0.061 | 0.133 | 0.092 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.092 0.063 DBMET00482 | DBMET00482 | |
| 0.028 | 0.102 | 0.067 | Argininosuccinate synthase inhibitor | 0.067 0.032 DBMET00482 | DBMET00482 | |
| 0.052 | 0.126 | 0.085 | Keratolytic | 0.085 0.043 DBMET00482 | DBMET00482 | |
| 0.107 | 0.182 | 0.171 | Interleukin 6 antagonist | 0.171 0.063 DBMET00051 0.166 0.068 DBMET00482 | DBMET00051 | |
| 0.021 | 0.099 | 0.081 | Ornithine carbamoyltransferase inhibitor | 0.081 0.021 DBMET00482 | DBMET00482 | |
| 0.077 | 0.159 | 0.1 | Factor V inhibitor | 0.1 0.068 DB00540 | DB00540 | |
| 0.047 | 0.133 | 0.092 | NMDA receptor antagonist | 0.092 0.052 DBMET00482 | DBMET00482 | |
| 0.046 | 0.137 | 0.084 | Adrenaline agonist | 0.084 0.053 DB00540 | DB00540 | |
| 0.021 | 0.111 | 0.048 | Mannosidase inhibitor | 0.048 0.027 DBMET00482 | DBMET00482 | |
| 0.055 | 0.146 | 0.078 | GABA B receptor agonist | 0.078 0.046 DBMET00482 | DBMET00482 | |
| 0.027 | 0.118 | 0.045 | GABA B receptor antagonist | 0.045 0.025 DBMET00482 | DBMET00482 | |
| 0.019 | 0.111 | 0.049 | Adenosine deaminase inhibitor | 0.049 0.031 DBMET00482 | DBMET00482 | |
| 0.012 | 0.108 | 0.037 | Phosphoglycerate kinase inhibitor | 0.037 0.022 DBMET00482 | DBMET00482 | |
| 0.102 | 0.198 | 0.149 | I kappa B kinase epsilon inhibitor | 0.149 0.121 DB00540 | DB00540 | |
| 0.014 | 0.116 | 0.033 | HMG CoA reductase inhibitor | 0.033 0.026 DBMET00051 0.033 0.026 DBMET00482 | DBMET00482 | |
| 0.029 | 0.137 | 0.067 | Carbonic anhydrase stimulant | 0.067 0.034 DB00540 | DB00540 | |
| 0.023 | 0.138 | 0.085 | NMDA 2 receptor antagonist | 0.085 0.041 DBMET00482 | DBMET00482 | |
| 0.03 | 0.15 | 0.194 | Histidine decarboxylase inhibitor | 0.194 0.014 DBMET00482 | DBMET00482 | |
| 0.059 | 0.183 | 0.093 | Mucolytic | 0.093 0.088 DBMET00482 | DBMET00482 | |
| 0.149 | 0.279 | 0.291 | Toll-Like receptor 7 agonist | 0.291 0.116 DBMET00051 0.272 0.129 DBMET00052 0.262 0.137 DBMET00482 | DBMET00051 | |
| 0.048 | 0.179 | 0.124 | Topoisomerase II inhibitor | 0.124 0.064 DBMET00051 | DBMET00051 | |
| 0.148 | 0.28 | 0.288 | Toll-Like receptor agonist | 0.288 0.119 DBMET00051 0.268 0.133 DBMET00052 0.279 0.125 DBMET00482 | DBMET00051 | |
| 0.033 | 0.17 | 0.072 | Topoisomerase II alpha inhibitor | 0.072 0.059 DBMET00051 | DBMET00051 | |
| 0.013 | 0.153 | 0.041 | Phosphorylase inhibitor | 0.041 0.036 DBMET00052 | DBMET00052 | |
| 0.063 | 0.205 | 0.123 | Cyclooxygenase 3 inhibitor | 0.123 0.075 DBMET00482 | DBMET00482 | |
| 0.021 | 0.168 | 0.048 | Baculoviral IAP repeat-containing protein inhibitor | 0.048 0.026 DB00540 | DB00540 | |
| 0.053 | 0.202 | 0.192 | Amylase inhibitor | 0.192 0.047 DBMET00482 | DBMET00482 | |
| 0.019 | 0.171 | 0.043 | Antibiotic Aminoglycoside-like | 0.034 0.029 DBMET00052 0.043 0.018 DBMET00482 | DBMET00482 | |
| 0.038 | 0.191 | 0.055 | Lipocortins synthesis agonist | 0.055 0.05 DBMET00482 | DBMET00482 | |
| 0.056 | 0.217 | 0.117 | Toll-Like receptor 4 antagonist | 0.095 0.079 DBMET00051 0.117 0.047 DBMET00482 | DBMET00482 | |
| 0.097 | 0.258 | 0.267 | Antioxidant | 0.242 0.088 DBMET00051 0.231 0.095 DBMET00052 0.267 0.075 DBMET00482 | DBMET00482 | |
| 0.011 | 0.176 | 0.041 | Opioid mu receptor agonist | 0.041 0.039 DBMET00482 | DBMET00482 | |
| 0.078 | 0.248 | 0.212 | Nitric oxide antagonist | 0.191 0.071 DBMET00051 0.18 0.076 DBMET00052 0.212 0.063 DBMET00482 | DBMET00482 | |
| 0.076 | 0.258 | 0.232 | Hepatoprotectant | 0.216 0.056 DBMET00051 0.216 0.056 DBMET00052 0.232 0.049 DBMET00482 | DBMET00482 | |
| 0.116 | 0.308 | 0.336 | Immunosuppressant | 0.315 0.106 DBMET00051 0.297 0.117 DBMET00052 0.336 0.094 DBMET00482 | DBMET00482 | |
| 0.009 | 0.215 | 0.03 | Plasmepsin I inhibitor | 0.03 0.021 DBMET00482 | DBMET00482 | |
| 0.126 | 0.337 | 0.309 | Apoptosis antagonist | 0.261 0.117 DBMET00051 0.254 0.124 DBMET00052 0.309 0.08 DBMET00482 | DBMET00482 | |
| 0.149 | 0.361 | 0.417 | Cyclophilin D inhibitor | 0.344 0.126 DBMET00051 0.358 0.116 DBMET00052 0.417 0.082 DBMET00482 | DBMET00482 | |
| 0.031 | 0.25 | 0.117 | Somatostatin 1 agonist | 0.117 0.025 DBMET00482 | DBMET00482 | |
| 0.004 | 0.225 | 0.026 | RNA-directed RNA polymerase stimulant | 0.026 0.023 DBMET00482 | DBMET00482 | |
| 0.027 | 0.269 | 0.065 | Ca(v)3.2 blocker | 0.065 0.029 DBMET00051 | DBMET00051 | |
| 0.012 | 0.254 | 0.039 | Growth hormone release inhibitor | 0.039 0.032 DBMET00482 | DBMET00482 | |
| 0.069 | 0.311 | 0.318 | Growth hormone agonist | 0.318 0.029 DBMET00482 | DBMET00482 | |
| 0.026 | 0.272 | 0.051 | Alpha 1b adrenoreceptor agonist | 0.051 0.032 DB00540 | DB00540 | |
| 0.015 | 0.266 | 0.046 | Protein 50S ribosomal subunit inhibitor | 0.046 0.045 DBMET00051 | DBMET00051 | |
| 0.051 | 0.326 | 0.147 | Histone deacetylase SIRT1 inhibitor | 0.147 0.064 DB00540 | DB00540 | |
| 0.046 | 0.325 | 0.196 | Toll-Like receptor 3 antagonist | 0.196 0.006 DB00540 0.12 0.03 DBMET00052 | DB00540 | |
| 0.054 | 0.333 | 0.214 | Hypolipemic | 0.214 0.085 DBMET00051 0.164 0.123 DBMET00052 0.165 0.123 DBMET00482 | DBMET00051 | |
| 0.105 | 0.385 | 0.332 | Antibacterial | 0.221 0.206 DBMET00052 0.332 0.113 DBMET00482 | DBMET00482 | |
| 0.035 | 0.317 | 0.198 | Thrombolytic | 0.198 0.053 DBMET00482 | DBMET00482 | |
| 0.101 | 0.385 | 0.248 | Sodium/bile acid cotransporter inhibitor | 0.222 0.159 DBMET00051 0.248 0.13 DBMET00052 0.202 0.185 DBMET00482 | DBMET00052 | |
| 0.009 | 0.304 | 0.11 | Antineoplastic antibiotic | 0.097 0.048 DBMET00051 0.086 0.053 DBMET00052 0.11 0.042 DBMET00482 | DBMET00482 | |
| 0.049 | 0.347 | 0.186 | Interleukin antagonist | 0.186 0.092 DBMET00482 | DBMET00482 | |
| 0.009 | 0.317 | 0.039 | Somatostatin 1 antagonist | 0.039 0.027 DBMET00482 | DBMET00482 | |
| 0.022 | 0.336 | 0.045 | Parathyroid hormone antagonist | 0.045 0.031 DBMET00482 | DBMET00482 | |
| 0.022 | 0.39 | 0.081 | ATPase (Vacuolar H+) inhibitor | 0.081 0.075 DBMET00052 | DBMET00052 | |
| 0.032 | 0.416 | 0.126 | DNA polymerase I inhibitor | 0.122 0.067 DBMET00051 0.113 0.074 DBMET00052 0.126 0.064 DBMET00482 | DBMET00482 | |
| 0.008 | 0.411 | 0.055 | NMDA 2B receptor antagonist | 0.055 0.036 DBMET00482 | DBMET00482 | |
| 0.078 | 0.513 | 0.291 | Caspase 3 stimulant | 0.291 0.083 DBMET00051 0.279 0.09 DBMET00052 0.288 0.085 DBMET00482 | DBMET00051 | |
| 0.025 | 0.496 | 0.213 | Angiogenesis stimulant | 0.213 0.088 DBMET00482 | DBMET00482 | |
| 0.077 | 0.613 | 0.435 | Interleukin 2 agonist | 0.282 0.088 DBMET00051 0.32 0.061 DBMET00052 0.435 0.019 DBMET00482 | DBMET00482 | |
| 0.008 | 0.546 | 0.04 | Somatostatin 5 agonist | 0.04 0.019 DBMET00482 | DBMET00482 | |
| 0.036 | 0.666 | 0.257 | Immunomodulator | 0.257 0.11 DBMET00482 | DBMET00482 | |
| 0.044 | 0.68 | 0.154 | Death-associated protein kinase 2 inhibitor | 0.154 0.098 DBMET00482 | DBMET00482 | |
| 0.008 | 0.756 | 0.092 | Aminoacyl-tRNA synthetase inhibitor | 0.092 0.055 DBMET00482 | DBMET00482 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |